当前位置:首页 - 行情中心 - 尚荣医疗(002551) - 财务分析 - 现金流量表

尚荣医疗

(002551)

  

流通市值:22.06亿  总市值:30.52亿
流通股本:6.11亿   总股本:8.45亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金966,709,611.77650,496,729.51450,935,122.491,297,944,556.7
  收到的税费返还34,973,658.5923,785,302.2113,025,068.7845,082,219.81
  收到其他与经营活动有关的现金19,289,819.8114,384,743.66,663,740.2253,301,990.31
  经营活动现金流入小计1,020,973,090.17688,666,775.32470,623,931.491,396,328,766.82
  购买商品、接受劳务支付的现金580,433,233.76440,203,123.57254,120,563.78867,342,947.97
  支付给职工以及为职工支付的现金187,353,516.72130,666,389.2571,991,131.12276,504,078.7
  支付的各项税费39,939,200.7930,855,085.1911,292,499.0538,080,462
  支付其他与经营活动有关的现金94,498,495.6284,962,685.9235,508,030.5993,454,490.68
  经营活动现金流出小计902,224,446.89686,687,283.93372,912,224.541,275,381,979.35
  经营活动产生的现金流量净额118,748,643.281,979,491.3997,711,706.95120,946,787.47
二、投资活动产生的现金流量:
  收回投资收到的现金1,353,625,902.111,174,625,902.11605,279,874.171,362,561,532.31
  取得投资收益收到的现金9,394,796.366,192,571.432,968,563.543,736,544.1
  处置固定资产、无形资产和其他长期资产收回的现金净额4,001,732.764,001,737.483,106.52,255,129.51
  收到的其他与投资活动有关的现金---113,146.38
  投资活动现金流入小计1,367,022,431.231,184,820,211.02608,251,544.211,368,666,352.3
  购建固定资产、无形资产和其他长期资产支付的现金17,382,611.3610,952,448.29,990,070.8382,147,569.65
  投资支付的现金1,273,000,000992,000,000517,000,0001,373,500,000
  投资活动现金流出小计1,290,382,611.361,002,952,448.2526,990,070.831,455,647,569.65
  投资活动产生的现金流量净额76,639,819.87181,867,762.8281,261,473.38-86,981,217.35
三、筹资活动产生的现金流量:
  取得借款收到的现金20,000,000---
  收到其他与筹资活动有关的现金29,200,0001,700,0001,650,00036,273,128.13
  筹资活动现金流入小计49,200,0001,700,0001,650,00036,273,128.13
  偿还债务支付的现金292,215,880.09267,215,880.09206,465,880.0921,060,000
  分配股利、利润或偿付利息支付的现金9,611,897.082,247,501.66968,478.811,033,633.53
  支付其他与筹资活动有关的现金60,250,00060,250,00060,250,0008,544,331.13
  筹资活动现金流出小计362,077,777.17329,713,381.75267,684,358.8940,637,964.66
  筹资活动产生的现金流量净额-312,877,777.17-328,013,381.75-266,034,358.89-4,364,836.53
四、汇率变动对现金及现金等价物的影响-2,841,438.662,553,446.916,574,034.3917,140,717.37
五、现金及现金等价物净增加额-120,330,752.68-141,612,680.63-80,487,144.1746,741,450.96
  加:期初现金及现金等价物余额453,987,150.22453,987,150.22453,987,150.22407,245,699.26
  期末现金及现金等价物余额333,656,397.54312,374,469.59373,500,006.05453,987,150.22
补充资料:
  净利润--4,520,153.56-25,912,519.2
  资产减值准备--10,253.94-9,154,823.65
  固定资产和投资性房地产折旧-43,400,505.39-87,871,937.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-43,400,505.39-87,871,937.63
  无形资产摊销-7,363,866.18-14,519,146.79
  长期待摊费用摊销-788,638.29-2,502,099.42
  处置固定资产、无形资产和其他长期资产的损失-3,104.67--124,830.39
  固定资产报废损失---1,607,173.67
  公允价值变动损失-3,638,102.83--1,322,766.63
  财务费用-5,102,165.01--8,834,281.72
  投资损失--7,087,511.07--2,701,178.47
  递延所得税--1,094,371.68--1,562,490.84
  其中:递延所得税资产减少--678,780.71--2,348,698.01
    递延所得税负债增加--415,590.97-786,207.17
  存货的减少-24,852,438.73-105,767,900.84
  经营性应收项目的减少-69,158,862.33--144,575,483.92
  经营性应付项目的增加--122,303,311.68-2,896,228.26
  现金的期末余额-312,374,469.59-453,987,150.22
  减:现金的期初余额-453,987,150.22-407,245,699.26
  现金及现金等价物的净增加额--141,612,680.63-46,741,450.96
公告日期2025-10-282025-08-262025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑